Previous Page  7 / 13 Next Page
Information
Show Menu
Previous Page 7 / 13 Next Page
Page Background

Page 47

Notes:

conferenceseries

.com

Volume 10

Journal of Carcinogenesis & Mutagenesis: Open Access

Asia Pacific Oncologists & Hospice 2019

May 13-14, 2019

May 13-14, 2019 Singapore

Annual Meeting on

Asia Pacific Oncologists, Hospice and Palliative Care

J Carcinog Mutagen 2019, Volume 10

DOI: 10.4172/2157-2518-C1-006

Mucinous colorectal cancer presenting as pseudomyxoma peritonei: A case report

Clarissa Marie Cruz

Bulacan Medical Center, Philippines

P

seudomyxoma peritonei is a rare locoregional disease and has incidence rate of one per million per year, characterized

by mucinous tumor on peritoneal surfaces producing excessive amounts of mucinous ascites. It was originally applied to

intraperitoneal mucinous spread originating froma cystadenoma of the appendix, which is benign, but currently was recognized

that aggressiveness may exist hence, a three pathologic subtypes were proposed, disseminated peritoneal adenomucinosis,

peritoneal mucinous adenocarcinoma, intermediate type PMP. A case of 71 years of female, Filipino who presented with

abdominal pain, in right lower quadrant, vague in character, with increasing abdominal girth, change in bowel movements,

anorexia and a pelvoabdominal mass 35x8 cm in size was noted. WAB CT scan revealed cystic pelvoabdominal mass; patient

had undergone laparotomy and noted mucinous discharge covering the whole peritoneum with mesenteric cystic mass 20x20

cm with mucoid discharge and perforation in cecal area. Biopsy result revealed pseudomyxoma peritonei, CEA was elevated, a

repeat CT scan was done and revealed recurrence of pelvoabdominal mass, bone scan showed possible bone metastasis. Patient

was then diagnosed with mucinous adenocarcinoma stage-4 with peritoneal and bone metastasis. Patient refused to undergo

colonoscopy. Mucinous Colorectal Adenocarcinoma (MCA) is a subtype of colorectal carcinoma with different biological

behavior; less common aggressiveness and prognosis than classical adenocarcinoma hence treatment approach is different.

MCA is more common in female, originates more common at proximal colon, diagnosed at advanced age and at a late stage.

New studies revealed that cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is a potential treatment.

clarissamariecruz@gmail.com